Fundamentals data is not available for this company.
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-25 | 1,039.08 | 461.98 | 238.22¢ | 3.2 | n/a | n/a | n/a | 0.0% |
31-Dec-26 | 497.75 | 55.52 | 19.00¢ | 39.9 | n/a | -92% | n/a | 0.0% |
31-Dec-27 | 271.80 | (6.19) | (31.63)¢ | n/a | n/a | n/a | n/a | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
Local Digest | 10-May-2009 | Washington Post |
Novavax Moves Closer to Licensing Bird Flu Vaccine | 27-Aug-2008 | Washington Post |
Business Briefing | 09-Aug-2008 | Washington Post |
Currency | US Dollars |
Share Price | $ 7.58 |
Change Today | $ 0.85 |
% Change | 12.63 % |
52 Week High | $14.68 |
52 Week Low | $5.39 |
Volume | 23,341,067 |
Shares Issued | 23.47m |
Market Cap | $177.93m |
RiskGrade | 720 |
Strong Buy | 2 |
Buy | 2 |
Neutral | 2 |
Sell | 1 |
Strong Sell | 1 |
Total | 8 |
Time | Volume / Share Price |
16:00 | 382,572 @ $7.58 |
15:59 | 100 @ $7.59 |
15:59 | 142 @ $7.59 |
15:59 | 2,265 @ $7.59 |
15:59 | 100 @ $7.59 |
You are here: research